jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Young PharmacistsNOW IN
Article

Examining Restless Leg Syndrome in Chronic Kidney Disease: Comprehensive Analysis

Rajesh Hadia1★, Harshal Joshi2, Kaushik Rana3, Feba Gleetas1, Dhruvi Tailor1, Vedant Tailor1, Hemraj Singh Rajput1★ Corresponding author

  1. 1Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, INDIA.
  2. 2Department of Nephrology, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, INDIA.
  3. 3Department of Neurology, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, INDIA.

CORRESPONDENCE

Rajesh Hadia

Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, INDIA.

docrajesh.hadia@gmail.com

Received: 12-02-2024; Revised: 30-03-2024; Accepted: 02-05-2024.

Volume 16, Issue 3 · pp. 556–562 · PUBLISHED · DOI: 10.5530/jyp.2024.16.69

View on JYP original site ↗

ABSTRACT

Background:Restless Leg Syndrome (RLS) is frequently associated with Chronic Kidney Disease (CKD), often under diagnosed and inadequately treated. Hence, this study aimed to ascertain the prevalence of CKD-induced RLS, exploring associated factors, pharmacotherapy and its impact on patients' quality of life. Materials and Methods:An observational prospective study conducted at Dhiraj General Hospital, Vadodara, from November 2022 to March 2023 included 246 CKD patients. Screening for RLS symptoms led to further evaluation and treatment in the Neurology department. Patients were re-evaluated after one month to assess treatment outcomes. Results:Analysis of 246 patients revealed a 6.91% prevalence of RLS in CKD. Factors contributing to RLS included anemia, advanced CKD stages and prolonged dialysis. Female gender emerged as a CKD risk factor. Pramipexole, Syndopa and Ropirinole effectively treated RLS in CKD patients. Conclusion:RLS substantially diminishes the quality of life in end-stage renal disease patients. Identification and management of contributing factors hold promise for improving outcomes and quality of life in CKD patients with RLS.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Hadia, R., Joshi, H., Rana, K., Gleetas, F., Tailor, D., Tailor, V., & Rajput, H. S. (). Examining Restless Leg Syndrome in Chronic Kidney Disease: Comprehensive Analysis. Journal of Young Pharmacists, 16(3), 556–562. https://doi.org/10.5530/jyp.2024.16.69